Ranked by engagement
Top topics — this month page 12
Ranked by replies, likes and views over this month, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
374 topics · page 12 of 13
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
eGFR fluctuation and the creatinine denominator problem
On the subject in the title: eGFR fluctuation and the creatinine denominator problem Working notes rather than a conclusion. Proposing that egfr fluctuation deserves a maintained page rather than a recurring…
|
2 | 10k | 6d | |
|
System suitability injections: if they failed, the run did not happen — the long version
System suitability injections: if they failed, the run did not happen — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about System suitability…
|
+2 | 6 | 6.2k | 1d |
|
About the Independent verification category
Janoshik, Medutest, PeptideMeter and VendorInvestigate results, how to submit a sample, and how to read what comes back. This post is a community wiki: any member at trust level 3 or above can edit it, and…
|
+1 | 5 | 5.8k | 23h |
|
Journal club: STEP 1 and the treatment-policy estimand
Journal club: STEP 1 and the treatment-policy estimand Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl J Med , 2021). Please read it before…
|
3 | 11k | 9h | |
|
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold?
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about Isotope patterns…
|
2 | 4.6k | 7h | |
|
[2026 update] Second opinions: how to seek one without burning the first
On the subject in the title: Second opinions: how to seek one without burning the first Working notes rather than a conclusion. Two things I would like separated before anyone answers on Second opinions,…
|
2 | 5.9k | 1d | |
|
Blinding yourself: practical methods and their limits — the long version
Blinding yourself: practical methods and their limits — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Blinding yourself,…
|
+7 | 11 | 1.8k | 22h |
|
The SOUL trial and oral semaglutide cardiovascular outcomes
Posting this under the heading it deserves: The SOUL trial and oral semaglutide cardiovascular outcomes Everything below is what sits behind that. Collecting what is known about SOUL trial and oral…
|
2 | 7.1k | 9h | |
|
About the Hydration & electrolytes category
Fluid intake, sodium, potassium and magnesium, and the very ordinary causes of week-two malaise. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 3.6k | 18h | |
|
How the vendor documentation pages are maintained, and by whom
How the vendor documentation pages are maintained, and by whom I have a specific reason for asking rather than idle curiosity, and the context is below. Vendor documentation pages keeps being re-asked here…
|
2 | 6k | 4h | |
|
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this number means before I…
|
+1 | 5 | 719 | 2d |
|
What TRIUMPH is designed to answer, and why we should not pre-empt it
What TRIUMPH is designed to answer, and why we should not pre-empt it I have a specific reason for asking rather than idle curiosity, and the context is below. TRIUMPH keeps being re-asked here and I think…
|
+4 | 8 | 142 | 6h |
|
About the Oral incretins category
Oral semaglutide, orforglipron and the absorption problem. PIONEER and OASIS data. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 6.2k | 20d | |
|
Revisiting: Spike-and-recover accuracy for a peptide assay
Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I was wrong about Spike-and-recover accuracy in a thread last spring and I…
|
2 | 6.8k | 21h | |
|
SURPASS-2 and the comparator dose question that will not go away — what changed since
Posting this under the heading it deserves: SURPASS-2 and the comparator dose question that will not go away — what changed since Everything below is what sits behind that. What changes if the standard…
|
+2 | 6 | 5.5k | 7h |
|
MS/MS sequence confirmation: what it costs and when it is worth it
MS/MS sequence confirmation: what it costs and when it is worth it — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
|
+2 | 6 | 2.7k | 1d |
|
Type 1 diabetes: off-label use and the evidence gap
On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. Type 1 diabetes, and specifically the version of it that the documentation does not…
|
2 | 2.3k | 1d | |
|
A community side-effect dataset, with its response rate and biases
A community side-effect dataset, with its response rate and biases — setting out what I have, and where I think it stops being reliable. Community side-effect dataset: setting out the arithmetic in full,…
|
2 | 5.1k | 19h | |
|
Coming back to: When a red flag was a misunderstanding, and the retraction
When a red flag was a misunderstanding, and the retraction I have a specific reason for asking rather than idle curiosity, and the context is below. Red flag — I have the observation and I do not trust my…
|
+6 | 10 | 257 | 21h |
|
Drawing up with one needle and injecting with another
On the subject in the title: Drawing up with one needle and injecting with another Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same thing…
|
+1 | 5 | 6.9k | 1d |
|
Why a pen's dose steps are fixed and what that costs you
The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. A question about a device rather than about a compound,…
|
4 | 2.5k | 23h | |
|
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about chain of custody in a thread last spring and I would like…
|
2 | 7.3k | 5h | |
|
Coming back to: Storing in the door of the fridge is worse than you think
On the subject in the title: Storing in the door of the fridge is worse than you think Working notes rather than a conclusion. Asking about the failure mode rather than the procedure, because the procedure is…
|
+2 | 6 | 2.1k | 1d |
|
PCOS and metabolic overlap: what is and is not studied
On the subject in the title: PCOS and metabolic overlap: what is and is not studied Working notes rather than a conclusion. PCOS and metabolic overlap, from the point of view of someone who has read the…
|
3 | 6.6k | 1d | |
|
How to ask about something you suspect is a bad idea — a second dataset
How to ask about something you suspect is a bad idea — a second dataset — that is the question, and I have not found it answered plainly anywhere I have looked. Counting it rather than describing it, because…
|
2 | 3.3k | 4h | |
|
How this community escalates rather than diagnoses — does this still hold?
The question in the title: How this community escalates rather than diagnoses — does this still hold? I will give what I have already checked below so nobody repeats it. Working notes on community escalates…
|
4 | 90 | 29d | |
|
Second pass at: Cagrilintide molecular characteristics and analytical considerations
On the subject in the title: Second pass at: Cagrilintide molecular characteristics and analytical considerations Working notes rather than a conclusion. Something about Cagrilintide molecular characteristics…
|
4 | 5k | 21d | |
|
Follow-up: Patterns that reliably precede a problem, documented
On the subject in the title: Patterns that reliably precede a problem, documented Working notes rather than a conclusion. A follow-up question about Patterns that I did not know to ask the first time. The…
|
2 | 70 | 1d | |
|
Publication bias detection and its low power
On the subject in the title: Publication bias detection and its low power Working notes rather than a conclusion. Working notes on publication bias detection rather than a conclusion. I would rather post the…
|
2 | 3.2k | 1d | |
|
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. The question about peer-to-peer review that I actually want answered is the second…
|
2 | 1.2k | 1d |